Abstract:The therapeutic potential of benzimidazole has brought them widespread recognition as a class of heterocyclic compounds having nitrogen-containing rings. In recent years, there has been a lot of focus on synthesizing these molecules in order to reveal a broad range of biological actions. Therefore, a novel series of 1H-benzo[ d ]imidazole-5-carboxamide derivatives were designed, synthesized, and investigated for their antioxidant and enzyme inhibitory activities. The structural elucidation of synthesized compounds was accomplished by a variety of spectroscopic techniques, such as elemental analysis, 1 H and 13 C NMR, and LC-MS. Using the DPPH and FRAP techniques, the antioxidant activity of newly synthesized compounds was assessed. With IC 50 values of 81.45, 72.14, and 77.35 μM, respectively, in the DPPH assay and 86.07, 75.02, and 81.14 μM, respectively, in the FRAP assay, the compounds 10c, 10f, and 10 g shown have significant antioxidant activity in comparisons with reference drugs ascorbic acid and Trolox. Furthermore, the inhibitory activity of xanthine oxidase (XO) and lipoxygenase (LOX) enzymes was assessed for the most potent molecules. Compounds 10c, 10f, and 10 g show superior inhibitory effects than reference drugs allopurinol and baicalein, with IC 50 values of 19.52, 13.95, and 15.83 μM, respectively, against LOX and 26.14, 18.43, and 22.05 μM, respectively, against the XO enzyme. Moreover, studies using molecular docking were conducted to gain a deeper understanding of the interactions between the 3NM8 and 1N8Q protein and the most effective compounds, 10c, 10f, and 10 g. While compared to the reference medications, the studied compounds showed substantial docking scores and binding affinities, as indicated by docking studies. Through the use of drug-likeness and structure-activity relationships (SAR), an association between the newly synthesized compounds' biological and physicochemical properties was established.

Synthesis, Crystal Structure, Biological Evaluation and in Silico Studies on Novel (e)‐1‐(substituted Benzylidene)‐4‐(3‐isopropylphenyl)thiosemicarbazone Derivatives

Synthesis, Structure, in Silico ADME Evaluation and in Vitro Antioxidant of (E)-N-(4-ethylphenyl)-2-(isomeric Methylbenzylidene) Thiosemicarbazone Derivatives

Crystal Structure Analysis of Three (E)-N-(3-methyl, 5-Fluorinephenyl)-2-(4-substituted Benzylidene)thiosemicarbazone Derivatives: Experimental and Theoretical Studies

Synthesis, Crystal Structure and Antifungal Activity of (E)-1-(4-Methylbenzylidene)-4-(3-Isopropylphenyl) Thiosemicarbazone: Quantum Chemical and Experimental Studies

Synthesis, Spectral Characteristics, Weak Interactions, Electronic Properties and Biological Activity of (E)-1-(4-hydroxybenzylidene)-4-(3-isopropylphenyl)thiosemicarbazone: an Experimental and Theoretical Approach

SYNTHESIS, CRYSTAL STRUCTURE, QUANTUM CHEMICAL CALCULATION AND MOLECULAR DOCKING ON (<i>E</i>)-1-(4-FLUOROBENZYLIDENE)-4-(3,5-DIMETHYLPHENYL)THIOSEMICARBAZO NE

Crystal Structure Analysis of (e)‐n‐(3,5‐dimethylphenyl)‐2‐(substituted Benzylidene)thiosemicarbazone: Experimental and Theoretical Studies

Synthesis, Crystal Structure and Non-covalent Interactions Analysis of Novel N-substituted Thiosemicarbazone

Study on the Synthesis and Theoretical Calculation of a Chlorine‐substituted Thiosemicarbazone Derivative

Synthesis, Characterization, X-Ray Single-Crystal Structure, Potentiometric Measurements, Molecular Modeling, and Bioactivity Screening of Some Thiosemicarbazones

Semicarbazone, thiosemicarbazone tailed isoxazoline-pyrazole: synthesis, DFT, biological and computational assessment

Synthesis, Biological Activities and 3D-QSAR Studies of (R)-2-phenyl-4,5-dihydrothiazole-4-carboxamide Derivatives Containing a Sulfur Ether Moiety

Potential thiosemicarbazone-based enzyme inhibitors: Assessment of antiproliferative activity, metabolic enzyme inhibition properties, and molecular docking calculations

Synthesis, Structures, Drug-Likeness, in Vitro Evaluation and in Silico Docking on Novel N-benzoyl-N′-phenyl Thiourea Derivatives

Design and synthesis of novel 5,6-disubstituted pyridine-2,3-dione-3-thiosemicarbazone derivatives as potential anticancer agents.

Synthesis of Novel 2-Phenylsulfonylhydrazono-3-(2′,3′,4′,6′-tetra-o-acetyl-β-d-glucopyranosyl)thiazolidine-4-ones from Thiosemicarbazide Precursors

Design, synthesis, biological activity, molecular docking and computational studies on novel 1,4-disubstituted-1,2,3-Triazole-Thiosemicarbazone hybrid molecules

Synthesis, molecular docking, enzyme inhibition and antioxidant potential of new 1H-benzo[ d ]imidazole-5-carboxamide derivatives

Synthesis, characterization and biological evaluation of some novel sulfonylthiosemicarbazides

Analysis of Hydrogen Bonding and Weak Interactions in the Crystal Structure of (E)-N-(4-ethylphenyl)-2-(4-hydroxybenzylidene)thiosemicarbazone: Experimental and Theoretical Studies

Synthesis, characterization and anticancer screening of novel phenylbenzylidene thiosemicarbazone derivatives